Skip to content

Conformal Medical Announces Presentation of US Feasibility Study Data at TCT 2019 in San Francisco

NASHUA, N.H., Sept. 23, 2019 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data on the first human implants of its unique technology for the prevention of stroke in patients with atrial fibrillation (AFib) at the TCT 2019 meeting September 25, 2019 at 4:30pm. The study’s […]

Read More

Conformal Medical Announces First Human Use of Conformal LAA Seal for Stroke Prevention in US Feasibility Study

Nashua, NH – April 9, 2019 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, reports the first human use of its proprietary technology for the prevention of stroke in patients with atrial fibrillation (AFib). The case was performed by Robert Sommer, MD at New York-Presbyterian/Columbia University Medical Center […]

Read More